Thome Memorial Foundation; Alzheimer's Disease Drug Discovery Award
UCSF
2022/2024
Sandler Foundation; Program for Breakthrough Biomedical Research, New Frontier Award
UCSF
2022/2023
John A. Watson Faculty Scholar
UCSF
2021/2024
Ludwig Family Foundation; Early Career Award
UCSF
2021/2023
Grants and Funding
Molecular determinants and consequences of disease-specific tau conformers in neurons and glia | NIH | 2026-09-09 - 2031-08-31 | Role: Principal Investigator
Multiscale structural approaches to define ADRD-associated tau filaments and cellular dysfunction | NIH | 2026-09-01 - 2031-07-31 | Role: Co-Principal Investigator
Cell Type Specific Drug Repurposing for Alzheimer's Disease | NIH | 2026-06-01 - 2031-05-31 | Role: Co-Principal Investigator
Identification of Regulatory Mechanisms Operating in Rare Pathogenic Astrocyte Subsets in Multiple Sclerosis with a Novel Genomic Technology | NIH | 2023-08-01 - 2028-07-31 | Role: Co-Principal Investigator
Structural characterization of tau aggregation variability and maturity in isolated cell types of the brain | NIH/NINDS | 2023-08-01 - 2028-07-31 | Role: Co-Principal Investigator
Structural characterization of tau aggregation variability and maturity in isolated cell types of the brain | NIH | 2023-08-01 - 2028-07-31 | Role: Co-Principal Investigator
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology | NIH/NINDS | 2023-08-01 - 2028-07-31 | Role: Co-Principal Investigator
Molecular mechanisms of selective vulnerability of neurons to tauopathy | NIH/NIA | 2023-08-01 - 2028-07-31 | Role: Co-Principal Investigator
Molecular mechanisms of selective vulnerability of neurons to tauopathy | NIH | 2023-06-01 - 2028-02-29 | Role: Co-Principal Investigator
Structural characterization of tau aggregation variability and maturity in isolated cell types of the brain | NIH | 2023-08-01 - 2026-07-31 | Role: Co-Principal Investigator
Relationships between conformational strains of tau and amyloid-beta, TREM2 and APOE variants, and phenotypic variations of Alzheimer's Disease | NIH | 2018-09-30 - 2023-03-31 | Role: Principal Investigator
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 45
Targeting glial PD-1/PD-L1 restores microglial homeostasis and reduces neuronal hyperactivity in an Alzheimer's disease model.
Park T, Chang L, Chung SW, Lee S, Bae S, Condello C, Kim YH, Lee J, Kim HJ, Kwon HK, Suh M| | PubMed
Author Correction: High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.
Carroll EC, Yang H, Powell WC, Charvat AF, Oehler A, Jones JG, Montgomery KM, Yung A, Millbern Z, Taylor AIP, Wilkinson M, Ranson NA, Radford SE, Vinueza NR, DeGrado WF, Mordes DA, Condello C, Gestwicki JE| | PubMed
Xu L, Yang H, Leon J, Li X, Oehler A, Modavi C, Abate AR, Condello C| | PubMed
β-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity.
Holmes BB, Weigel TK, Chung JM, Kaufman SK, Apresa BI, Byrnes JR, Kumru KS, Vaquer-Alicea J, Gupta A, Rose IVL, Zhang Y, Nana AL, Alter D, Grinberg LT, Spina S, Leung KK, Miller BL, Condello C, Kampmann M, Seeley WW, Coutinho-Budd JC, Wells JA| | PubMed
High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.
Carroll EC, Yang H, Powell WC, Charvat AF, Oehler A, Jones JG, Montgomery KM, Yung A, Millbern Z, Taylor AIP, Wilkinson M, Ranson NA, Radford SE, Vinueza NR, DeGrado WF, Mordes DA, Condello C, Gestwicki JE| | PubMed
β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity.
Holmes BB, Weigel TK, Chung JM, Kaufman SK, Apresa BI, Byrnes JR, Kumru KS, Vaquer-Alicea J, Gupta A, Rose IVL, Zhang Y, Nana AL, Alter D, Grinberg LT, Spina S, Leung KK, Condello C, Kampmann M, Seeley WW, Coutinho-Budd JC, Wells JA| | PubMed
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis.
Samelson AJ, Ariqat N, McKetney J, Rohanitazangi G, Bravo CP, Bose R, Travaglini KJ, Lam VL, Goodness D, Dixon G, Marzette E, Jin J, Tian R, Tse E, Abskharon R, Pan H, Carroll EC, Lawrence RE, Gestwicki JE, Eisenberg D, Kanaan NM, Southworth DR, Gross JD, Gan L, Swaney DL, Kampmann M| | PubMed
Expanding the Prion Paradigm to Include Alzheimer and Parkinson Diseases.
Aβ and tau prions feature in the neuropathogenesis of Down syndrome.
Condello C, Maxwell AM, Castillo E, Aoyagi A, Graff C, Ingelsson M, Lannfelt L, Bird TD, Keene CD, Seeley WW, Perl DP, Head E, Prusiner SB| | PubMed
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy.
Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, Chin M, Li Y, Le D, Zhou Y, Condello C, Grinberg LT, Seeley WW, Miller BL, Mok SA, Gestwicki JE, Cuervo AM, Luo W, Gan L| | PubMed
Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
Ayers JI, Lee J, Monteiro O, Woerman AL, Lazar AA, Condello C, Paras NA, Prusiner SB| | PubMed
Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
Belsare KD, Wu H, Mondal D, Bond A, Castillo E, Jin J, Jo H, Roush AE, Pilla KB, Sali A, Condello C, DeGrado WF| | PubMed
Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer's disease pathology in Down syndrome.
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.
Aoyagi A, Condello C, Stöhr J, Yue W, Rivera BM, Lee JC, Woerman AL, Halliday G, van Duinen S, Ingelsson M, Lannfelt L, Graff C, Bird TD, Keene CD, Seeley WW, DeGrado WF, Prusiner SB| | PubMed
Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.
Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR| | PubMed
Mapping interactions with the chaperone network reveals factors that protect against tau aggregation.
Mok SA, Condello C, Freilich R, Gillies A, Arhar T, Oroz J, Kadavath H, Julien O, Assimon VA, Rauch JN, Dunyak BM, Lee J, Tsai FTF, Wilson MR, Zweckstetter M, Dickey CA, Gestwicki JE| | PubMed
Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease.
Condello C, Lemmin T, Stöhr J, Nick M, Wu Y, Maxwell AM, Watts JC, Caro CD, Oehler A, Keene CD, Bird TD, van Duinen SG, Lannfelt L, Ingelsson M, Graff C, Giles K, DeGrado WF, Prusiner SB| | PubMed
Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.
Johnson NR, Condello C, Guan S, Oehler A, Becker J, Gavidia M, Carlson GA, Giles K, Prusiner SB| | PubMed
A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.
Stöhr J, Wu H, Nick M, Wu Y, Bhate M, Condello C, Johnson N, Rodgers J, Lemmin T, Acharya S, Becker J, Robinson K, Kelly MJS, Gai F, Stubbs G, Prusiner SB, DeGrado WF| | PubMed
Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.